Medicare Enrolled
Dr. Manuel Reyes, M.D.
Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac & Remote— Practice combining cardiac and remote services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reyes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reyes? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reyes
Dr. Manuel Reyes is a cardiovascular disease in Houston, TX, with 14 years in practice. Based on federal Medicare data, Dr. Reyes performed 4,856 Medicare services across 2,511 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reyes received a total of $112,925 from 35 pharmaceutical and/or device companies across 978 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reyes is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ Top 17% volume in TX$ $112,925 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,856
Medicare services
Top 17% in TX for cardiovascular disease
2,511
Unique beneficiaries
$153
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~347 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 772 | $42 | $118 |
| Office visit, established patient, complex (40-54 min) | 564 | $134 | $215 |
| Office visit, established patient (30-39 min) | 457 | $99 | $145 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 312 | $20 | $125 |
| Echocardiogram, transthoracic | 299 | $147 | $1,404 |
| Remote patient monitoring device, 30 days | 288 | $40 | $128 |
| Hospital follow-up visit, high complexity | 286 | $96 | $175 |
| Remote patient monitoring management, 20 min/month | 255 | $39 | $128 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 203 | $56 | $575 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 198 | $600 | $1,949 |
| Electrocardiogram (EKG), 12-lead | 181 | $11 | $125 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 156 | $1,057 | $3,250 |
| Initial hospital admission, high complexity | 127 | $136 | $300 |
| Hospital follow-up visit, moderate complexity | 124 | $63 | $150 |
| Chronic care management, first 20 min/month | 88 | $49 | $120 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 54 | $9 | $40 |
| Chronic care management, additional 20 min/month | 50 | $38 | $118 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 46 | $15 | $49 |
| Ultrasonic guidance for blood vessel access | 45 | $11 | $40 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 37 | $1,937 | $6,073 |
| Remote pacemaker monitoring, 90 days | 35 | $18 | $94 |
| New patient office visit, complex (60-74 min) | 33 | $163 | $476 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 31 | $151 | $503 |
| Replacement of aortic valve through the skin and femoral artery | 24 | $610 | $3,600 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $82 | $295 |
| Ultrasound of both sides of head and neck blood flow | 20 | $136 | $658 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $14 | $92 |
| Placement and subsequent removal of device to protect brain from embolism through catheter using imaging guidance | 17 | $108 | $342 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $18 | $65 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 16 | $32 | $105 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 15 | $678 | $2,345 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 15 | $19 | $159 |
| Cardiac catheterization | 15 | $187 | $1,500 |
| New patient office visit (45-59 min) | 14 | $101 | $396 |
| Insertion of heart rhythm monitor under skin | 12 | $3,525 | $12,000 |
| Office visit, established patient (20-29 min) | 12 | $67 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.4% high complexity
25.8% medium
65.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$112,925
Total received (2018-2024)
Avg $16,132/year across 7 years
Top 5% in TX for cardiovascular disease
35
Companies
978
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$85,303 (75.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,975 (16.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,646 (7.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,402
2023$4,915
2022$7,928
2021$24,325
2020$26,521
2019$17,297
2018$28,538
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$64,278
Edwards Lifesciences Corporation
$29,346
Cardiovascular Systems Inc.
$12,302
Biosense Webster, Inc.
$1,275
BOSTON SCIENTIFIC CORPORATION
$1,015
ABIOMED
$812
E.R. Squibb & Sons, L.L.C.
$456
Medtronic Vascular, Inc.
$410
Medtronic, Inc.
$326
Boston Scientific Corporation
$286
BIOTRONIK INC.
$259
PFIZER INC.
$251
AstraZeneca Pharmaceuticals LP
$228
Novartis Pharmaceuticals Corporation
$199
Janssen Pharmaceuticals, Inc
$177
GE HealthCare
$163
Amgen Inc.
$154
Acutus Medical, Inc.
$135
HeartFlow, Inc.
$124
CSL Behring
$106
SANOFI-AVENTIS U.S. LLC
$85
Impulse Dynamics (USA) Inc.
$81
Novo Nordisk Inc
$69
Bardy Diagnostics, Inc.
$68
Esperion Therapeutics, Inc.
$60
Chiesi USA, Inc.
$41
G Medical Diagnostic Services, Inc.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$38
CARDIVA MEDICAL, INC.
$26
Kiniksa Pharmaceuticals International, plc
$26
Tactile Systems Technology Inc
$22
Bard Peripheral Vascular, Inc.
$20
Siemens Medical Solutions USA, Inc.
$18
iRhythm Technologies, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 93.8% of total payments
Associated products mentioned in payments ›
ACCENT · ACCOLADE SR · ALLURE QUADRA · AMPLATZER Occluders · AMPLATZER TorqVue Delivery Systm · ASSURITY · AVEIR · Accent Pacemaker · Acticor · Allia · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Arcalyst · Asahi Fielder coronary guide wire · Assurity Pacemaker · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CLEVIPREX · CLOSUREFAST · CONFIRM RX · CRT-Ds · CRT-Ps · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · CareLink Express · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Carto Smarttouch · CartoSound · Cartomerge · Confidense · Confirm Rx · CorPath Imaging System · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DRAGONFLY OPSTAR · DURATA · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · Endurant · Ensite Cardiac Mapping System · FARXIGA · FFRct · FORTIFY ASSURA · Flexitouch Plus · Fortify Assura · GALLANT · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · HAWKONE · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate II LVAS · ICDs · Impella · JARDIANCE · JOT DX · Kcentra · LATITUDE Communicator Power Supply · LEQVIO · LUTONIX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MERLIN@HOME · MITRACLIP · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NEXLETOL · ONYX FRONTIER · OPTIS · OPTISURE · Omnilink Elite vascular stent system · Optimizer · Optimizer Smart System · Optis Coronary Imaging System · Ozempic · PERCLOSE PROGLIDE · Pacemakers · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Portico Transcatheter Aortic HV · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Repatha · Resolute · Rivacor · SAPIEN 3 Ultra RESILIA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Ultreon · Unify Assura CRT Defibrillator · VYNDAQEL · WATCHMAN FLX · XARELTO · Xience Sierra CSS · Xience Sierra Coronary Stent · Xience V coronary stent system · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for cardiovascular disease in TX.
Equivalent to $2,325 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
396
Per 100K population
8.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reyes is a cardiac & remote specialist, with above-average Medicare volume (top 17% in TX), and high industry engagement (consulting-driven, top 5%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reyes experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Reyes performed 772 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reyes receive payments from pharmaceutical companies?
Yes. Dr. Reyes received a total of $112,925 from 35 companies across 978 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reyes's costs compare to other cardiovascular diseases in Houston?
Dr. Reyes's average Medicare payment per service is $153. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reyes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology